Add to ORKGGolimumab, a human antibody to tumour necrosis factor a given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexat
OBJECTIVE: To assess the efficacy and safety of intravenous administration of golimumab in patients ...
Objective. To assess the efficacy, safety, and pharmacology of subcutaneous administration of golimu...
The Author(s) 2013. This article is published with open access at Springerlink.com Rheumatoid arthri...
To assess 2-year golimumab efficacy/safety in patients with active rheumatoid arthritis (RA) who had...
Abstract: Golimumab is the fifth tumor necrosis factor (TNF) alpha inhibitor approved by the Food an...
To assess the safety and efficacy of golimumab in methotrexate (MTX)-naive patients with active rheu...
Objective: The phase III GO-FORWARD study examined the efficacy and safety of golimumab in patients ...
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthrit...
Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthriti...
Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and mark...
© 2020 Taylor & Francis Group, LLCTumor necrosis factor (TNF) is a pro-inflammatory cytokine and its...
Objective. To assess the safety and efficacy of golimumab in methotrexate (MTX)-naive patients with ...
Objective. To assess the efficacy, safety, and pharmacology of subcutaneous administration of golimu...
PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HT...
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an in...
OBJECTIVE: To assess the efficacy and safety of intravenous administration of golimumab in patients ...
Objective. To assess the efficacy, safety, and pharmacology of subcutaneous administration of golimu...
The Author(s) 2013. This article is published with open access at Springerlink.com Rheumatoid arthri...
To assess 2-year golimumab efficacy/safety in patients with active rheumatoid arthritis (RA) who had...
Abstract: Golimumab is the fifth tumor necrosis factor (TNF) alpha inhibitor approved by the Food an...
To assess the safety and efficacy of golimumab in methotrexate (MTX)-naive patients with active rheu...
Objective: The phase III GO-FORWARD study examined the efficacy and safety of golimumab in patients ...
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthrit...
Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthriti...
Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and mark...
© 2020 Taylor & Francis Group, LLCTumor necrosis factor (TNF) is a pro-inflammatory cytokine and its...
Objective. To assess the safety and efficacy of golimumab in methotrexate (MTX)-naive patients with ...
Objective. To assess the efficacy, safety, and pharmacology of subcutaneous administration of golimu...
PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HT...
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an in...
OBJECTIVE: To assess the efficacy and safety of intravenous administration of golimumab in patients ...
Objective. To assess the efficacy, safety, and pharmacology of subcutaneous administration of golimu...
The Author(s) 2013. This article is published with open access at Springerlink.com Rheumatoid arthri...